Healthcare
Live Price
Offline$63.48
+0.00% today
1Y Change
—
Window
No data
Historical coverage is still loading
We are still backfilling 1Y daily history for this symbol. Some charts may stay empty until more data arrives.
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Catalent, Inc. (CTLT) is a Healthcare stock with a market cap of $11.52B. The stock last traded around $63.48. Baseline metrics include revenue growth of +2.5%, EPS growth of -350.0%, a dividend yield of 0.0%. What stands out right now is revenue +2.5%, EPS -350.0%, free cash flow +81.7% with operating margin -17.1% and ROIC -8.5%. Valuation is more restrained than many high-expectation growth names at price/sales 2.6. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines CTLT price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
CTLT
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
CTLT Max Drawdown
—
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for CTLT and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$3.1B
-22.6% YoY
FY Net Income
$173.0M
-70.4% YoY
Free Cash Flow
-$25.5M
+89.9% YoY
Revenue Growth
+2.5%
EPS Growth
-350.0%
Gross Margin
21.8%
Net Margin
-23.8%
Income statement
USD
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenue | 4.4B | 4.3B | 4.8B | 4.0B | 3.1B |
| Gross Profit | 953M | 1.1B | 1.6B | 1.4B | 983M |
| Operating Income | -749M | -137M | 349M | 354M | 144M |
| EBITDA | -284M | 266M | 1.1B | 1.1B | 640M |
| Net Income | -1.0B | -232M | 499M | 585M | 173M |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
USD
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Cash & Equivalents | 289M | 280M | 449M | 896M | 953M |
| Total Assets | 9.8B | 10.8B | 10.5B | 9.1B | 7.8B |
| Total Liabilities | 6.1B | 6.1B | 5.7B | 5.2B | 4.9B |
| Shareholder Equity | 3.6B | 4.6B | 4.8B | 3.9B | 2.9B |
| Total Debt | 4.9B | 4.8B | 4.2B | 3.2B | 3.0B |
| Net Debt | 4.6B | 4.6B | 3.8B | 2.3B | 2.1B |
Cash flow positioning
Latest Full Year
Operating Cash Flow
440M
+1.7% YoY
Capital Expenditures
466M
+32.1% YoY
Free Cash Flow
26M
+89.9% YoY
Key ratios
Gross Margin
21.8%
Operating Margin
-17.1%
Net Margin
-23.8%
ROE
-25.3%
Debt / Equity
1.36x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.